EIGR
Eiger BioPharmaceuticals, Inc.
EIGR
EIGR
Delisted
EIGR was delisted on the 10th of April, 2024.
40 hedge funds and large institutions have $128M invested in Eiger BioPharmaceuticals, Inc. in 2014 Q2 according to their latest regulatory filings, with 12 funds opening new positions, 9 increasing their positions, 12 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
25% less repeat investments, than reductions
Existing positions increased: 9 | Existing positions reduced: 12
Holders
40
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$29.1M | |
| 2 | +$7.63M | |
| 3 | +$2.4M | |
| 4 |
Axa
Paris,
France
|
+$774K |
| 5 |
RPAM
Rhenman & Partners Asset Management
Stockholm,
Sweden
|
+$737K |
Top Sellers
| 1 | -$6.55M | |
| 2 | -$2.44M | |
| 3 | -$1.15M | |
| 4 |
BIT
BlackRock Institutional Trust
San Francisco,
California
|
-$905K |
| 5 |
VAM
Visium Asset Management
New York
|
-$570K |